XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 26.68

+1.3%

11:32 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Robert K. who wrote (10764)	7/13/1999 7:56:00 AM
From: Arthur Radley	Read Replies (1) of 17367

Robert, I caught the tail-end of a CNBC report on Amgen and the allowance of the FDA to skip the Phase III trial. Did I understand this drug is for the treatment of sepsis? They will interview the CEO of Amgen at 9:30 EDt but I will not be available for this time frame.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next